A team of researchers at the University of California, Los Angeles (UCLA) has introduced a virtual Gram staining technique ...

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

A team of researchers at the Swiss Federal Laboratories for Materials Science and Technology (EMPA) have developed a battery ...

New findings suggest that pet dogs may serve as an overlooked conduit for transferring antibiotic-resistant Salmonella to ...

Pet dogs could be an unexpected source of harmful bacteria like Salmonella, new research suggests. A team of researchers from ...

Antibiotic-resistant Salmonella is a serious public health concern that has increased in recent years as the bacteria have ...

Antibiotic-resistant Salmonella is a serious public health concern that has increased in recent years as the bacteria have developed ways to survive drugs. According to the U.S. Centers for Disease ...

Our pet dogs may be giving us dangerous infections and spreading antibiotic-resistant bacteria, a study has found.

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that CEO Neal Koller will present at the following investor conferences during J.P.

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.